Huntexil (pridopidine) / Prilenia  >>  Phase 3
Welcome,         Profile    Billing    Logout  

4 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Huntexil (pridopidine) / Prilenia
MermaiHD, NCT00665223: A Study of Treatment With Pridopidine (ACR16) in Participants With Huntington's Disease

Completed
3
437
Europe
ACR16, Pridopidine, Placebo
Teva Branded Pharmaceutical Products R&D, Inc.
Huntington's Disease
06/10
06/10
NCT04556656 / 2020-002822-10: PRidopidine's Outcome On Function in Huntington Disease, PROOF- HD

Active, not recruiting
3
499
Europe, Canada, US, RoW
Pridopidine, Placebo
Prilenia
Huntington Disease
03/23
03/24
NCT04615923: HEALEY ALS Platform Trial - Regimen D Pridopidine

Completed
2/3
163
US
Pridopidine, Matching Placebo
Merit E. Cudkowicz, MD, Prilenia Therapeutics
Amyotrophic Lateral Sclerosis
07/22
07/22
HEALEY ALS, NCT04297683: Platform Trial - Master Protocol

Active, not recruiting
2/3
1500
US
Zilucoplan, Verdiperstat, CNM-Au8, Pridopidine, SLS-005 Trehalose, ABBV-CLS-7262, DNL343
Merit E. Cudkowicz, MD, Massachusetts General Hospital
Amyotrophic Lateral Sclerosis
07/25
04/26

Download Options